Product #1 pi main [(b)(4)] an event of device embolization was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported incident could not be conclusively determined; however, information from the field indicates, "the patient had heavy physical activity on the day of embolization and was thought to be the reason." per ifu, patients should avoid strenuous activities for a minimum of 1 month post-device implant.Strenuous activities may lead to the increased risk of adverse events.A 34 mm amplatzer atrial septal occluder was used for replacement.
|
On (b)(6) 2018, a 32 mm amplatzer atrial septal occluder was implanted.On (b)(6) 2018, the device was found to have embolized and was retrieved by snare; the patient was reported stable after.Per report, the patient had heavy physical activity on the day of embolization, which was 8 days after implant.The physical activity is thought to be the reason for embolization.On (b)(6) 2018, a redo procedure was successfully completed with a 34 mm amplatzer atrial septal occluder.The patient was reported stable.
|